We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
+15.99%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$362B
AUM Growth
+$32.2B
(+9.8%)
Cap. Flow
+$418M
Cap. Flow
% of AUM
0.12%
Top 10 Holdings %
Top 10 Hldgs %
32.89%
Holding
3,469
New
192
Increased
989
Reduced
1,979
Closed
199
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$5.9B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$2.1B |
| 3 |
NVIDIA
NVDA
|
+$1.2B |
| 4 |
Amazon
AMZN
|
+$575M |
| 5 |
Cisco
CSCO
|
+$511M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Nuveen Growth Opportunities ETF
NUGO
|
+$2.48B |
| 2 |
Cintas
CTAS
|
+$1.73B |
| 3 |
UnitedHealth
UNH
|
+$856M |
| 4 |
Apple
AAPL
|
+$577M |
| 5 |
BOLD
Boundless Bio
BOLD
|
+$399M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.82% |
| 2 | Financials | 13.01% |
| 3 | Consumer Discretionary | 11.23% |
| 4 | Communication Services | 9.04% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2376
Rocket Pharmaceuticals
RCKT
$355M
| $1.56M | ﹤0.01% |
638,515
+460,222
| +258% | +$2.33M |
|
|
MAG
2377
DELISTED
MAG Silver
MAG
| $1.56M | ﹤0.01% |
73,720
-8,163
| -10% | -$145K |
|
2378
Vestis
VSTS
$2.03B
| $1.56M | ﹤0.01% |
272,241
-5,119
| -2% | -$35.9K |
|
|
DFTX
2379
Definium Therapeutics
DFTX
$5.66B
| $1.56M | ﹤0.01% |
239,842
-26,209
| -10% | -$172K |
|
2380
Matthews International
MATW
$878M
| $1.55M | ﹤0.01% |
64,953
-50,960
| -44% | -$1.07M |
|
2381
Anavex Life Sciences
AVXL
$232M
| $1.55M | ﹤0.01% |
168,377
-20,664
| -11% | -$176K |
|
|
CBL
2382
CBL Properties
CBL
$1.81B
| $1.55M | ﹤0.01% |
61,040
-19,483
| -24% | -$480K |
|
|
SAIL
2383
SailPoint Inc
SAIL
$8.7B
| $1.55M | ﹤0.01% |
67,662
-8,081
| -11% | -$153K |
|
|
ITOS
2384
DELISTED
iTeos Therapeutics
ITOS
| $1.54M | ﹤0.01% |
154,424
-149,226
| -49% | -$1.2M |
|
2385
Forward Air
FWRD
$466M
| $1.53M | ﹤0.01% |
62,311
-29,402
| -32% | -$522K |
|
2386
Insteel Industries
IIIN
$624M
| $1.53M | ﹤0.01% |
41,072
-4,157
| -9% | -$139K |
|
2387
United States Antimony
UAMY
$808M
| $1.53M | ﹤0.01% |
+700,113
| New | +$1.98M |
|
2388
MiMedx Group
MDXG
$635M
| $1.53M | ﹤0.01% |
249,785
-60,093
| -19% | -$400K |
|
2389
Select Water Solutions
WTTR
$2.34B
| $1.52M | ﹤0.01% |
175,536
-6,869
| -4% | -$59.3K |
|
2390
Camden National
CAC
$927M
| $1.5M | ﹤0.01% |
37,044
-3,559
| -9% | -$139K |
|
2391
Shutterstock
SSTK
$216M
| $1.5M | ﹤0.01% |
79,188
-5,973
| -7% | -$105K |
|
2392
Mesa Laboratories
MLAB
$540M
| $1.5M | ﹤0.01% |
15,924
-3,500
| -18% | -$384K |
|
2393
Enviri
NVRI
$620M
| $1.5M | ﹤0.01% |
172,309
-44,427
| -20% | -$326K |
|
2394
Accel Entertainment
ACEL
$1.01B
| $1.5M | ﹤0.01% |
127,043
-12,693
| -9% | -$142K |
|
2395
Shenandoah Telecom
SHEN
$637M
| $1.49M | ﹤0.01% |
109,177
-26,861
| -20% | -$341K |
|
2396
Opko Health
OPK
$936M
| $1.49M | ﹤0.01% |
1,126,557
-250,324
| -18% | -$342K |
|
2397
Transcat
TRNS
$805M
| $1.48M | ﹤0.01% |
17,247
-3,856
| -18% | -$315K |
|
2398
Northeast Community Bancorp
NECB
$369M
| $1.48M | ﹤0.01% |
63,770
+13,359
| +27% | +$302K |
|
2399
Fortrea Holdings
FTRE
$1.82B
| $1.48M | ﹤0.01% |
299,538
-28,833
| -9% | -$155K |
|
2400
Embecta
EMBC
$204M
| $1.47M | ﹤0.01% |
152,188
-29,284
| -16% | -$329K |
|
Similar funds
VFT
Nuveen's Q2 2025 Portfolio in Review
As of Q2 2025, Nuveen held 3,469 positions worth $362B, up 9.8% from $330B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Nuveen's Q2 2025 filing shows 192 new, 989 increased, 1,979 reduced and 199 closed positions. Its largest new stake was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M. The largest sale was Nuveen Growth Opportunities ETF, an estimated $2.48B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 28% a quarter earlier, followed by Financials and Consumer Discretionary.
- Nuveen's largest Q2 2025 buy was Janus Henderson AAA CLO ETF: 4,258,000 shares worth $216M.
- Nuveen added most to Meta Platforms (Facebook) in Q2 2025, an estimated $5.9B increase.
- Nuveen's biggest Q2 2025 reduction was Cintas, cutting an estimated $1.73B.
- Nuveen fully exited Nuveen Growth Opportunities ETF in Q2 2025, selling an estimated $2.48B.
- Nuveen's ten largest holdings make up 33% of its $362B portfolio in Q2 2025.
- Nuveen opened 192 new positions and closed 199 in Q2 2025.
- Nuveen's portfolio value rose 9.8% quarter-over-quarter to $362B.
Based on Nuveen's 13F filing for Q2 2025, filed 12 Aug 2025.